Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.350
-0.160 (-10.60%)
May 15, 2026, 4:00 PM EDT - Market closed

Allarity Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.25-11.23-24.52-11.9-16.06-26.65
Depreciation & Amortization
-0.05-0.010.010.040.060.11
Stock-Based Compensation
0.680.680.41-0.071.756.37
Other Adjustments
1.471.426.68-4.16-2.24-0.28
Changes in Accounts Payable
-1.36-1.14-4.112.176.21-1.31
Changes in Accrued Expenses
-2.8-2.73.540.04-4.727.2
Changes in Income Taxes Payable
0.010.010.020.02-0.020.01
Changes in Unearned Revenue
--0.21---
Changes in Other Operating Activities
-2.97-1.850.411.13-1.79-0.32
Operating Cash Flow
-16.63-14.82-17.35-12.75-16.82-14.89
Capital Expenditures
-0.06-0.01-0.3--0.02-
Proceeds from Sale of Intangible Assets
----0.811.01
Investing Cash Flow
-0.06-0.01-0.3-0.791.01
Long-Term Debt Issued
20-1.341.0514
Long-Term Debt Repaid
---1.34-3.7--2.95
Net Long-Term Debt Issued (Repaid)
20-0-2.6511.05
Issuance of Common Stock
013.8437.3519.14-32.85
Repurchase of Common Stock
-3.45-3.19----
Net Common Stock Issued (Repurchased)
-3.4510.6537.3519.14-32.85
Issuance of Preferred Stock
--2.941.16--
Repurchase of Preferred Stock
---3.5-6.65-2.31-
Net Preferred Stock Issued (Repurchased)
---0.56-5.49-2.31-
Other Financing Activities
------0.08
Financing Cash Flow
19.2510.6536.7911-1.3133.82
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.92-0.670.23-0.11-0.19-0.68
Net Cash Flow
2.55-4.1819.14-1.75-17.3419.94
Free Cash Flow
-16.69-14.83-17.65-12.75-16.84-14.89
FCF Margin
-66764.00%-4633.75%----
Free Cash Flow Per Share
-1.07-1.03-10.98-3765.14-29708.80-49159.50
Levered Free Cash Flow
1.51-16.93-25.38-19.68-20.34-19.92
Unlevered Free Cash Flow
-19.82-18.31-27.88-13.62-31.77-20.75
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q